首页> 外文会议>ICMSI;International conference of molecular simulations and applied informatics technologies >Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas
【24h】

Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas

机译:基于取代尿素药效团模型的Raf-1激酶抑制剂的虚拟筛选

获取原文

摘要

A three-dimensional (3D) quantitative pharmacophore model was developed from a training set of structurally diverse substituted ureas against Raf-1 kinase, which was well validated to be highly predictive by two methods, namely, test set prediction and cross-validated method. Then a virtual database searching was performed with the pharmacophore model as a 3D query, and the bioactivities of the retrieved hits were predicted by the pharmacophore. Subsequently, molecular docking was carried out on the selected hits whose estimated IC50 were less than 1 μM Finally, 29 hits, which exhibited good estimated activities, high docking scores, similar binding mode to experimentally proven compounds and favorable drug-like properties, were identified as potential leads against Raf-1 kinase. The study may facilitate the discovery and rational design of novel leads with potent inhibitory activity targeting Raf-1 kinase. Softwares used: Catalyst 4.10, Gold 3.0.1
机译:从针对Raf-1激酶的结构多样的取代尿素训练集建立了三维(3D)定量药效团模型,该模型已通过测试集预测和交叉验证方法两种方法很好地验证了其高预测性。然后使用药效团模型作为3D查询执行虚拟数据库搜索,并通过药效团预测检索到的命中的生物活性。随后,对估计IC50小于1μM的选定命中分子进行了分子对接。最后,鉴定出29个命中分子,它们表现出良好的估算活性,高对接得分,与经实验验证的化合物相似的结合模式以及良好的类药物特性作为潜在的抗Raf-1激酶。这项研究可能有助于发现和合理设计具有针对Raf-1激酶的强抑制活性的新线索。所使用的软件:Catalyst 4.10,Gold 3.0.1

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号